This has buyout written all over it. Once all obligations of the deal are complete, this company will most likely make $EPGL their subsidiary. Will it be a cash deal or will it be a share transfer. Works out just fine for me either way.

The new company will not want EPGL's tech going to competitors. And they will want to buy out EPGL before their PPS goes super nova. You can bet Hayes made it clear to them that EPGL won't be undercut the way COO tried to do. I think Hayes and PwC would accept an .88 offer.

Gotta love EPGL's current tech:

Advanced Technologies for Contact Lenses.
Advanced Cell Regeneration Technology to Treat Eye Disease.
Advanced Cell Regeneration Technology to Treat Hearing Loss.
Advanced Nerve Ablation Device.
Advanced Epidural Device.
Advanced Trigger Point Needle Device.
Advanced Micron Resolution Motor for Smart Medical Devices.
Advanced Platform Technology for Development of Smart Medical devices.
Real Time Sensor Technologies for Connectivity to a Global Network.
Real Time Data Applications for Athletic Teams, Workforces and Military Forces.

Also, you have to wonder what type of tech EPGL will developing with this new company that isn't on the above list.




R